Pulmonary granuloma formation during latent Cryptococcus neoformans infection in C3HeB/FeJ mice involves progression through three immunological phases

Simple item page
dc.contributor.authorBetancourt, Jovany J.en
dc.contributor.authorDing, Minnaen
dc.contributor.authorYoder, J. Marinaen
dc.contributor.authorMutyaba, Issaen
dc.contributor.authorAtkins, Hannah M.en
dc.contributor.authorDe la Cruz, Gabrielaen
dc.contributor.authorMeya, David B.en
dc.contributor.authorNielsen, Kirstenen
dc.date.accessioned2025-01-17T20:15:30Zen
dc.date.available2025-01-17T20:15:30Zen
dc.date.issued2025-01-14en
dc.description.abstractCryptococcus neoformans is a fungal pathogen that can cause lethal disease in immunocompromised patients. Immunocompetent host immune responses, such as formation of pulmonary granulomas, control the infection and prevent disseminated disease. Little is known about the immunological conditions establishing the latent infection granuloma in the lungs. To investigate this, we performed an analysis of pulmonary immune cell populations, cytokine changes, and granuloma formation during infection with a latent disease-causing clinical isolate in C3HeB/FeJ mice over 360 days. We found that latently infected mice progress through three phases of granuloma formation where different immune profiles dominate: an early phase characterized by eosinophilia, high IL-4/IL-13, and C. neoformans proliferation in the lungs; an intermediate phase characterized by multinucleated giant cell formation, high IL-1α/IFNγ, granuloma expansion, and increased blood antigen levels; and a late phase characterized by a significant expansion of T cells, granuloma condensation, and decreases in lung fungal burden and blood antigen levels. These findings highlight a complex series of immune changes that occur during the establishment of granulomas that control C. neoformans in the lungs and lay the foundation for studies to identify critical beneficial immune responses to Cryptococcus infections.en
dc.description.sponsorshipThis work was supported by the National Institutes of Health (R01AI134636 and R01NS118538 to K.N.). J.J.B. was supported by the National Institutes of Health (F31AI181528) and a University of Minnesota Medical Student Training Program (T32GM008244). I.M. was supported by the National Institutes of Health (T35AI118620) Medical Student Summer Research Program in Infection and Immunity. M.D. was supported by the National Institutes of Health (F30AI155292), a University of Minnesota Medical Student Training Program (T32GM008244), and a University of Minnesota Lung Biology Dinnaken Fellowship.en
dc.description.versionPublished versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.doihttps://doi.org/10.1128/mbio.03610-24en
dc.identifier.urihttps://hdl.handle.net/10919/124253en
dc.language.isoenen
dc.publisherAmerican Society for Microbiologyen
dc.subjectCryptococcus neoformansen
dc.subjectgranulomaen
dc.subjectlatent infectionen
dc.subjectcryptococcosisen
dc.subjectC3HeB/FeJen
dc.subjectadaptive immunityen
dc.subjectinnate immunityen
dc.subjectmycologyen
dc.subjectpathogenesisen
dc.subjecthost-pathogen interactionsen
dc.subjectpulmonary infectionen
dc.subjecttuberculosisen
dc.titlePulmonary granuloma formation during latent <i>Cryptococcus neoformans</i> infection in C3HeB/FeJ mice involves progression through three immunological phasesen
dc.title.serialmBioen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
betancourt-et-al-2025-pulmonary.pdf
Size:
2.8 MB
Format:
Adobe Portable Document Format
Description:
Published version
Download
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.5 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Scholarly Works, Biomedical Sciences and Pathobiology